Vesalius Biocapital Partners and SRIW have led a €10m funding round in Belgian pharmaceuticals company Euroscreen.
Other investors in the round included Life Sciences Research Partners VZW, Societe de Participation et de Gestion, Hunza Ventures and existing shareholders Fortis Private Equity, Compagnie du Bois Sauvage,...
XAnge Private Equity bought a minority stake in the group in 2007 for €3.5m
Catch up on essential features from this past week with our round-up of industry analysis
IPO sees Prime Ventures and Macquarie among vendors of existing shares worth a total of €153m
Business, founded in 2014, is currently at proof-of-concept stage for its product